198 related articles for article (PubMed ID: 1332026)
1. Structure of inositol monophosphatase, the putative target of lithium therapy.
Bone R; Springer JP; Atack JR
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10031-5. PubMed ID: 1332026
[TBL] [Abstract][Full Text] [Related]
2. High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy.
Gill R; Mohammed F; Badyal R; Coates L; Erskine P; Thompson D; Cooper J; Gore M; Wood S
Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):545-55. PubMed ID: 15858264
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inositol monophosphatase, the putative target of lithium therapy.
Pollack SJ; Atack JR; Knowles MR; McAllister G; Ragan CI; Baker R; Fletcher SR; Iversen LL; Broughton HB
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5766-70. PubMed ID: 8016062
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase activities: a novel target of lithium therapy.
Patel S; Yenush L; RodrÃguez PL; Serrano R; Blundell TL
J Mol Biol; 2002 Jan; 315(4):677-85. PubMed ID: 11812139
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and molecular properties of lithium-sensitive myo-inositol monophosphatase.
Parthasarathy L; Vadnal RE; Parthasarathy R; Devi CS
Life Sci; 1994; 54(16):1127-42. PubMed ID: 8152337
[TBL] [Abstract][Full Text] [Related]
6. Structure and mechanism of inositol monophosphatase.
Atack JR; Broughton HB; Pollack SJ
FEBS Lett; 1995 Mar; 361(1):1-7. PubMed ID: 7890024
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures.
Arai R; Ito K; Ohnishi T; Ohba H; Akasaka R; Bessho Y; Hanawa-Suetsugu K; Yoshikawa T; Shirouzu M; Yokoyama S
Proteins; 2007 May; 67(3):732-42. PubMed ID: 17340635
[TBL] [Abstract][Full Text] [Related]
8. Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure.
York JD; Ponder JW; Majerus PW
Proc Natl Acad Sci U S A; 1995 May; 92(11):5149-53. PubMed ID: 7761465
[TBL] [Abstract][Full Text] [Related]
9. Purification and biochemical characterization of Mycobacterium tuberculosis SuhB, an inositol monophosphatase involved in inositol biosynthesis.
Nigou J; Dover LG; Besra GS
Biochemistry; 2002 Apr; 41(13):4392-8. PubMed ID: 11914086
[TBL] [Abstract][Full Text] [Related]
10. Determination of the lithium binding site in inositol monophosphatase, the putative target for lithium therapy, by magic-angle-spinning solid-state NMR.
Haimovich A; Eliav U; Goldbourt A
J Am Chem Soc; 2012 Mar; 134(12):5647-51. PubMed ID: 22384802
[TBL] [Abstract][Full Text] [Related]
11. Calbindin D28k and S100B have a similar interaction site with the lithium-inhibitable enzyme inositol monophosphatase-1: a new drug target site.
Agam G; Almog O
J Med Chem; 2015 Feb; 58(4):2042-4. PubMed ID: 25665147
[TBL] [Abstract][Full Text] [Related]
12. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
Vadnal R; Parthasarathy R
Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
[TBL] [Abstract][Full Text] [Related]
13. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
Atack JR; Broughton HB; Pollack SJ
Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
[TBL] [Abstract][Full Text] [Related]
14. Structural elucidation of the binding site and mode of inhibition of Li(+) and Mg(2+) in inositol monophosphatase.
Dutta A; Bhattacharyya S; Dutta D; Das AK
FEBS J; 2014 Dec; 281(23):5309-24. PubMed ID: 25263816
[TBL] [Abstract][Full Text] [Related]
15. Stereochemistry at phosphorus of the reaction catalyzed by myo-inositol monophosphatase.
Fauroux CM; Lee M; Cullis PM; Douglas KT; Gore MG; Freeman S
J Med Chem; 2002 Mar; 45(6):1363-73. PubMed ID: 11882005
[TBL] [Abstract][Full Text] [Related]
16. Lack of genetic variation in the coding region of the myo-inositol monophosphatase gene in lithium-treated patients with manic depressive illness.
Steen VM; Gulbrandsen AK; Eiken HG; Berle JO
Pharmacogenetics; 1996 Feb; 6(1):113-6. PubMed ID: 8845858
[No Abstract] [Full Text] [Related]
17. Crystal structure and catalytic mechanism of the MJ0109 gene product: a bifunctional enzyme with inositol monophosphatase and fructose 1,6-bisphosphatase activities.
Johnson KA; Chen L; Yang H; Roberts MF; Stec B
Biochemistry; 2001 Jan; 40(3):618-30. PubMed ID: 11170378
[TBL] [Abstract][Full Text] [Related]
18. A structural basis for lithium and substrate binding of an inositide phosphatase.
Dollins DE; Xiong JP; Endo-Streeter S; Anderson DE; Bansal VS; Ponder JW; Ren Y; York JD
J Biol Chem; 2021; 296():100059. PubMed ID: 33172890
[TBL] [Abstract][Full Text] [Related]
19. Lithium therapy in the treatment of manic-depressive illness. Present status and future perspectives. A critical review.
Emilien G; Maloteaux JM; Seghers A; Charles G
Arch Int Pharmacodyn Ther; 1995; 330(3):251-78. PubMed ID: 8836446
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of inositol polyphosphate 1-phosphatase at 2.3-A resolution.
York JD; Ponder JW; Chen ZW; Mathews FS; Majerus PW
Biochemistry; 1994 Nov; 33(45):13164-71. PubMed ID: 7947723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
